Galera Therapeutics Inc - ESG Rating & Company Profile powered by AI
The webpage of Galera Therapeutics Inc was prepared by All Street Sevva using proprietary artificial intelligence. If you work at Galera Therapeutics Inc and you wish to licence your ESG aseessment, please get in touch. Browse to the end of this page for potential risks for Galera Therapeutics Inc based on industry, location and marketcap.
Galera Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 8.0, social score of 3.2 and governance score of 4.0.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Galera Therapeutics Inc | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Galera Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Galera Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Galera Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Galera Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Galera Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Galera Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Galera Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Galera Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Galera Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Galera Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Galera Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Galera Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Galera Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Galera Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Galera Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Galera Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Galera Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Galera Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.